Share
190 Posts.
lightbulb Created with Sketch. 91
clock Created with Sketch. 17/08/18
21:04
Share
Originally posted by perrier
↑
I wouldn't throw the Bell Potter baby out with the bathwater. The valuation of $2.30 is purely of the deal with Acadia, and includes a discount for a 40% chance of success at Phase3. So, in order
Expand
Originally posted by perrier
↑
I wouldn't throw the Bell Potter baby out with the bathwater. The valuation of $2.30 is purely of the deal with Acadia, and includes a discount for a 40% chance of success at Phase3. So, in order
Expand
Just to add to this, a recent MIT study using data for approvals from 2006 to 2015 shows an interesting upward trend in approvals from phase 3 testing to a point where over 70% of drugs undergoing phase 3 trials were approved in 2014 and even higher in 2015. The study shows different and higher approval figures from those previously accepted, so it may be that if BP was working off statistics rather than making their own assessment, they were relying on outdated figures.
(20min delay)